These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16218503)

  • 1. [Homocystein--an independent risk factor for cardiovascular and thrombotic diseases].
    Fowler B
    Ther Umsch; 2005 Sep; 62(9):641-6. PubMed ID: 16218503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine and cardiovascular disease: a review of the evidence.
    Wierzbicki AS
    Diab Vasc Dis Res; 2007 Jun; 4(2):143-50. PubMed ID: 17654449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
    Booth GL; Wang EE
    CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease.
    McKinley MC
    Proc Nutr Soc; 2000 May; 59(2):221-37. PubMed ID: 10946791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?
    Debreceni B; Debreceni L
    Cardiovasc Ther; 2012 Aug; 30(4):227-33. PubMed ID: 21884001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of B vitamins status and homocysteine levels in elderly Taiwanese.
    Chen KJ; Pan WH; Yang FL; Wei IL; Shaw NS; Lin BF
    Asia Pac J Clin Nutr; 2005; 14(3):250-5. PubMed ID: 16169836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
    Clarke R; Lewington S; Sherliker P; Armitage J
    Curr Opin Clin Nutr Metab Care; 2007 Jan; 10(1):32-9. PubMed ID: 17143052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine and arterial thrombosis: Challenge and opportunity.
    Di Minno MN; Tremoli E; Coppola A; Lupoli R; Di Minno G
    Thromb Haemost; 2010 May; 103(5):942-61. PubMed ID: 20352150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine, folic acid, B vitamins and cardiovascular risk.
    Blacher J; Safar ME
    J Nutr Health Aging; 2001; 5(3):196-9. PubMed ID: 11458292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of plasma homocysteine in natural menopause can not be explained by a lack of vitamin coenzyme availability: relevance to the risk of cardiovascular disease.
    Masse PG; Dosy J; Cole DE; Evrovski J; Mahuren JD; Coburn SP
    J Nutr Health Aging; 2005; 9(1):59-64. PubMed ID: 15750667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of hyperhomocysteinaemia in cardiovascular disease.
    Lievers KJ; Kluijtmans LA; Blom HJ
    Ann Clin Biochem; 2003 Jan; 40(Pt 1):46-59. PubMed ID: 12542910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine, B-vitamins and CVD.
    McNulty H; Pentieva K; Hoey L; Ward M
    Proc Nutr Soc; 2008 May; 67(2):232-7. PubMed ID: 18412997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hiperhomocysteinemia in active and passive smokers and the levels of folate and vitamin B6 in plasma].
    Marszałł ML; Makarowski R; Hinc S; Kłos M; Czarnowski W
    Przegl Lek; 2008; 65(10):486-90. PubMed ID: 19189529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Homocysteine. The cardiovascular risk factor of the next millennium?].
    Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
    An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Group B vitamins as new variables related to the cardiovascular risk].
    Granieri M; Bellisarii FI; De Caterina R
    Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine: evidence for a causal relationship with cardiovascular disease.
    Scott CH; Sutton MS
    Cardiol Rev; 1999; 7(2):101-7. PubMed ID: 10348972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.